Tenax Therapeutics Inc (TENX) Directors and Executive Officers

Officers & Directors

Christopher T. Giordano
President and Chief Executive Officer and Director

Robyn M. Hunter
Director

Stuart Rich, MD
Director

Declan Doogan, MD
Director

Cherry Bekaert LLP
We have served as the Company’s auditor

Lawrence R. Hoffman
Interim Chief Financial Officer (On behalf of the Registrant and as Principal Financial and Accounting Officer)

Almenoff, MD
Director

Gerald Proehl
Chairman of the Board and Director

Michael Davidson, MD
Director ,

Tenax Therapeutics Inc currently has 16 employees.

News about Tenax Therapeutics Inc Key Personnel

Tenax Therapeutics Expands Global Rights to Revolutionary Treatment for Pulmonary Hypertension

In a major breakthrough for the field of cardiovascular and pulmonary medicine, Tenax Therapeutics, a Phase 3, development-stage pharmaceutical company, has announced a significant expansion of its global development, commercial, and intellectual property rights to a life-changing treatment known as levosimendan. This development holds immense promise for patients suffering from pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).
Levosimendan, available in both oral and subcutaneous forms, has shown tremendous potential in addressing the high unmet medical need for this particular condition. This exciting announcement comes as Tenax Therapeutics Inc. shares tr...

Tenax Therapeutics Welcomes Dr. Javed Butler to Advisory Board as Strong Q3 2023 ROA Performance Points to Promising Future

Tenax Therapeutics, a leading specialty pharmaceutical company catering to unmet medical needs in cardiovascular and pulmonary diseases, has recently appointed renowned cardiologist and academician, Dr. Javed Butler, to its PH-HFpEF Scientific Advisory Board (SAB). This strategic move aims to enhance the company s expertise and drive innovation in the field. Additionally, the company s financial performance has portrayed significant growth, with its return on assets (ROA) surpassing industry averages during the third quarter of 2023.
Tenax Therapeutics Strengthens Scientific Advisory Board:
Dr. Javed Butler, an accomplished medical professional with expertise in heart failure and translatio...